SGTX

Sigilon Therapeutics, Inc. Common Stock
SGTX

Delisted

SGTX was delisted on the 10th of August, 2023.

Back to rankings
 

About: Sigilon Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is developing a new class of therapeutics and functional cures for patients with chronic diseases by providing stable and durable levels of therapeutic molecules to patients. Its lead product candidate, SIG-001, prevents bleeding in patients with moderate-severe to severe Hemophilia A.

Employees: 62

Healthcare Drug Manufacturers - General
Charts implemented using Lightweight Charts™